AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes
Abstract Efficient manufacture of recombinant adeno-associated virus (rAAV) vectors for gene therapy remains challenging. Packaging cell lines containing stable integration of the AAV rep/cap genes have been explored, however rAAV production needs to be induced using wild-type adenoviruses to promot...
Main Authors: | Weiheng Su, Leonard W. Seymour, Ryan Cawood |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48901-z |
Similar Items
-
Inducible HEK293 AAV packaging cell lines expressing Rep proteins
by: Lovro Jalšić, et al.
Published: (2023-09-01) -
The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
by: Adriana Gonzalez-Sandoval, et al.
Published: (2023-04-01) -
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination
by: Weiheng Su, et al.
Published: (2022-03-01) -
A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair
by: Leclerc Xavier, et al.
Published: (2009-04-01) -
Comprehensive mutagenesis maps the effect of all single-codon mutations in the AAV2 rep gene on AAV production
by: Nina K Jain, et al.
Published: (2024-03-01)